David Patteson and Greg Magoon have taken the reins of a new unit at Ampersand Capital Partners, the Portfolio Acceleration Team (PAT).
The Wellesley, Massachusetts-based firm (with an office in Amsterdam as well) is a mid-market private equity concern with AUM above $2 billion. Its focus is growth-oriented investment in the healthcare sector. Only last month it announced the close of the Ampersand Continuation Fund, with core asset Confluent Medical Technologies, which was oversubscribed.
Unlock this article instantly, along with the rest of our premium content and daily, weekly and monthly newsletters. We offer pay-as-you-go monthly subscriptions and discounted annual subscriptions with additional benefits: access to Alternatives Watch Research articles and our Annual Investor Compendium.